P-260PANOVA-3: A phase 3 study of tumor treating fields with nab-paclitaxel and gemcitabine for front-line treatment of locally advanced pancreatic adenocarcinoma (LAPC). (2nd July 2019) - Picozzi, V; Weinberg, U; Giladi, M; Bomzon, Z; Kirson, E